Stock AADI AADI BIOSCIENCE, INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News Aadi Bioscience, Inc.

Equities

AADI

US00032Q1040

Market Closed - Nasdaq
Other stock markets
 21:00:00 01/05/2024 BST 		5-day change 1st Jan Change
1.94 USD +1.04% Intraday chart for Aadi Bioscience, Inc. +5.43% -3.96%
03-13 Transcript : Aadi Bioscience, Inc., Q4 2023 Earnings Call, Mar 13, 2024
03-13 Earnings Flash (AADI) AADI BIOSCIENCE Posts Q4 Revenue $6.3M MT

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Aadi Bioscience to Report First Quarter 2024 Results and Corporate Update
PR
Aadi Bioscience to Present New Non-clinical Data Highlighting Combinability of nab-Sirolimus at the American Association for Cancer Research Annual Meeting
AQ
Aadi Bioscience Presents New Subgroup Analysis of Patients with Advanced Malignant PEComa of Gynecologic Origin Treated with nab-Sirolimus at Society of Gynecologic Oncology (SGO)
PR
Transcript : Aadi Bioscience, Inc., Q4 2023 Earnings Call, Mar 13, 2024
Earnings Flash (AADI) AADI BIOSCIENCE Posts Q4 Revenue $6.3M
MT
Aadi Bioscience, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
CI
Aadi Bioscience Announces Financial Results for the Fourth Quarter and Full-Year 2023 and Provides Corporate Update
PR
North American Morning Briefing : Stock Futures -2-
DJ
Aadi Bioscience to Report Fourth Quarter and Full-Year 2023 Results and Corporate Update
PR
North American Morning Briefing : Stock Futures Hover At Start of Busy Week
DJ
Aadi Bioscience Reports Supportive Data from Tumor Treatment Trial -- Shares Jump After Hours
MT
Aadi Bioscience Announces Publication of Long-Term Efficacy and Safety Data Further Supporting FYARRO® for the Treatment of Malignant PEComa
PR
Aadi Bioscience to Present at the TD Cowen 44th Annual Healthcare Conference
PR
North American Morning Briefing : Stock Futures -2-
DJ
Sector Update: Health Care Stocks Retreating Late Afternoon
MT
Top Midday Decliners
MT
Piper Sandler Cuts Aadi Bioscience's Price Target to $5 From $30, Keeps Overweight Rating
MT
Wall Street Set to Open Narrowly Mixed Ahead of PMI, Industrial Production Data
MT
Top Premarket Decliners
MT
HC Wainwright Downgrades Aadi Bioscience to Neutral From Buy
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. AADI Stock
  4. News Aadi Bioscience, Inc.